Product
Advertisement
ioMicroglia™ – Consistent iPSC-Derived Microglia, Ready in 10 Days!
ioMicroglia are cryopreserved human iPSC-derived microglia powered by bit.bio’s opti-ox™ precision reprogramming technology, built so scientists no longer have to battle with long differentiation protocols that produce inconsistent cell populations.
In just 10 days post-revival, ioMicroglia show:
ioMicroglia are available now. Request a quote today.
Product Specifications
Marker expression
TMEM119, P2RY12, IBA1
Vial size
1.5 million viable cells
Shipping format
Cryopreserved
Viability
>80%
Seeding density
37,000-39,500 cells/cm2
Seeding compatibility
6, 12, 24, 96 and 384 well plates
Validated functions
Phagocytosis, cytokine secretion, co-cultures with neurons
Price
Available on request
About bit.bio
bit.bio is an award-winning human synthetic biology company whose mission is to code cells for novel cures. They have developed an end-to-end platform for the creation of any human cell type. With their cutting-edge and patent-protected opti-ox<sup>™</sup> precision cell programing technology, bit.bio can deterministically program human induced pluripotent stem cells (iPSCs) into a chosen cell identity with unprecedented biological consistency at an industrial scale and approximately 10 times faster than conventional methods. Their platform has the potential to unlock a new generation of medicines.
Interested in seeing more content from bit.bio?
Discover all their latest news, webinars, products and more by clicking the link below.
Chosen for You
